1. Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers. (2nd October 2016) Authors: Sebbagh, Sihem; Roux, Julia; Dreyer, Chantal; Neuzillet, Cindy; de Gramont, Armand; Orbegoso, Cecilia; Hentic, Olivia; Hammel, Pascal; de Gramont, Aimery; Raymond, Eric; André, Thierry; Chibaudel, Benoist; Faivre, Sandrine Journal: Acta oncologica Issue: Volume 55:Number 9-10(2016) Page Start: 1168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma. (3rd June 2019) Authors: Faivre, Sandrine; Santoro, Armando; Kelley, Robin K.; Gane, Ed; Costentin, Charlotte E.; Gueorguieva, Ivelina; Smith, Claire; Cleverly, Ann; Lahn, Michael M.; Raymond, Eric; Benhadji, Karim A.; Giannelli, Gianluigi Journal: Liver international Issue: Volume 39:Number 8(2019) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. Issue 8 (9th August 2018) Authors: Van Cutsem, Eric; Hidalgo, Manuel; Canon, Jean‐Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlovic, Nebojsa; Radenkovic, Dejan; Verslype, Chris; Raymond, Eric; Cubillo, Antonio; Schueler, Armin; Zhao, Charles; Hammel, Pascal Journal: International journal of cancer Issue: Volume 143:Issue 8(2018) Page Start: 2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions. Issue 3 (4th March 2022) Authors: Brun, Sonia; Bestion, Eloïne; Raymond, Eric; Bassissi, Firas; Jilkova, Zuzana Macek; Mezouar, Soraya; Rachid, Madani; Novello, Marie; Tracz, Jennifer; Hamaï, Ahmed; Lalmanach, Gilles; Vanderlynden, Lise; Legouffe, Raphael; Stauber, Jonathan; Schubert, Thomas; Plach, Maximilian G.; Courcambeck, Jé... Journal: Autophagy Issue: Volume 18:Issue 3(2022) Page Start: 678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety data. (31st January 2019) Authors: Valle, Juan W; Borbath, Ivan; Rosbrook, Brad; Fernandez, Kathrine; Raymond, Eric Journal: Future oncology Issue: Volume 15:Number 11(2019) Page Start: 1219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib. (20th March 2014) Authors: Ronot, Maxime; Bouattour, Mohamed; Wassermann, Johanna; Bruno, Onorina; Dreyer, Chantal; Larroque, Béatrice; Castera, Laurent; Vilgrain, Valérie; Belghiti, Jacques; Raymond, Eric; Faivre, Sandrine Journal: Oncologist Issue: Volume 19:Number 4(2014) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel TGF-β inhibitors ready for prime time in onco-immunology. (2nd January 2017) Authors: de Gramont, Armand; Faivre, Sandrine; Raymond, Eric Journal: Oncoimmunology Issue: Volume 6:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19). (December 2020) Authors: Lièvre, Astrid; Turpin, Anthony; Ray-Coquard, Isabelle; Le Malicot, Karine; Thariat, Juliette; Ahle, Guido; Neuzillet, Cindy; Paoletti, Xavier; Bouché, Olivier; Aldabbagh, Kais; Michel, Pierre; Debieuvre, Didier; Canellas, Anthony; Wislez, Marie; Laurent, Lucie; Mabro, May; Colle, Raphael; Hardy-... Journal: European journal of cancer Issue: Volume 141(2020) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. C-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside. (August 2016) Authors: Szturz, Petr; Raymond, Eric; Faivre, Sandrine Journal: Oral oncology Issue: Volume 59(2016:Aug.) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models. Issue 12 (15th October 2019) Authors: Astorgues-Xerri, Lucile; Vázquez, Ramiro; Odore, Elodie; Rezai, Keyvan; Kahatt, Carmen; Mackenzie, Sarah; Bekradda, Mohamed; Coudé, Marie-Magdelaine; Dombret, Herve; Gardin, Claude; Lokiec, Francois; Raymond, Eric; Noel, Kay; Cvitkovic, Esteban; Herait, Patrice; Bertoni, Francesco; Riveiro, María E. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 12(2019) Page Start: 3067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗